KBC Group NV Sells 179,653 Shares of Sotera Health Company (NASDAQ:SHC)

KBC Group NV trimmed its stake in shares of Sotera Health Company (NASDAQ:SHC - Free Report) by 96.4% in the first quarter, according to the company in its most recent filing with the SEC. The firm owned 6,712 shares of the company's stock after selling 179,653 shares during the quarter. KBC Group NV's holdings in Sotera Health were worth $78,000 as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. Quarry LP acquired a new stake in Sotera Health during the fourth quarter worth approximately $28,000. Farther Finance Advisors LLC grew its stake in Sotera Health by 4,881.9% during the first quarter. Farther Finance Advisors LLC now owns 6,327 shares of the company's stock worth $70,000 after purchasing an additional 6,200 shares during the period. Tower Research Capital LLC TRC grew its stake in Sotera Health by 37.8% during the fourth quarter. Tower Research Capital LLC TRC now owns 5,975 shares of the company's stock worth $82,000 after purchasing an additional 1,640 shares during the period. Sterling Capital Management LLC grew its stake in Sotera Health by 58.5% during the fourth quarter. Sterling Capital Management LLC now owns 9,029 shares of the company's stock worth $124,000 after purchasing an additional 3,331 shares during the period. Finally, PNC Financial Services Group Inc. grew its stake in Sotera Health by 39.4% during the fourth quarter. PNC Financial Services Group Inc. now owns 9,302 shares of the company's stock worth $127,000 after purchasing an additional 2,627 shares during the period. Institutional investors and hedge funds own 91.03% of the company's stock.

Sotera Health Stock Performance

Shares of NASDAQ SHC traded down $0.09 during mid-day trading on Friday, hitting $11.80. The company had a trading volume of 806,138 shares, compared to its average volume of 1,232,598. Sotera Health Company has a 1 year low of $9.53 and a 1 year high of $17.08. The stock's 50-day moving average price is $12.06 and its 200-day moving average price is $12.27. The company has a current ratio of 2.46, a quick ratio of 2.19 and a debt-to-equity ratio of 5.55. The company has a market capitalization of $3.35 billion, a price-to-earnings ratio of 147.52 and a beta of 1.81.

Sotera Health (NASDAQ:SHC - Get Free Report) last posted its earnings results on Thursday, May 1st. The company reported $0.14 EPS for the quarter, topping the consensus estimate of $0.12 by $0.02. Sotera Health had a return on equity of 41.08% and a net margin of 2.24%. The business had revenue of $254.52 million during the quarter, compared to analysts' expectations of $245.56 million. During the same period in the previous year, the business earned $0.13 earnings per share. The firm's revenue was up 2.6% on a year-over-year basis. On average, sell-side analysts forecast that Sotera Health Company will post 0.61 earnings per share for the current year.

Analysts Set New Price Targets

Several research analysts have issued reports on SHC shares. Piper Sandler cut their price target on Sotera Health from $15.00 to $13.00 and set a "neutral" rating on the stock in a report on Wednesday, April 23rd. The Goldman Sachs Group upgraded Sotera Health from a "neutral" rating to a "buy" rating and upped their price objective for the company from $14.00 to $17.00 in a research note on Monday, May 5th. Barclays decreased their target price on Sotera Health from $15.00 to $13.00 and set an "overweight" rating for the company in a research report on Tuesday, June 24th. Finally, Wall Street Zen raised Sotera Health from a "hold" rating to a "buy" rating in a research report on Saturday, June 28th. One investment analyst has rated the stock with a hold rating and five have given a buy rating to the company's stock. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $16.00.

About Sotera Health

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.